BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 41703)

  • 1. [Gonadotropin secretion following pernasal stimulation with synthetic gonadotropin releasing hormone (GnRH) and a highly effective GnRH-analog in healthy men and prepubertal boys].
    Happ J; Depper M; Weber T; Hartmann U; Kollmann F; Beyer J
    Endokrinologie; 1979 Apr; 74(1):33-41. PubMed ID: 41703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin and testosterone secretion in normal human males after stimulation with gonadotropin-releasing hormone (GnRH) or potent GnRH analogs using different modes of application.
    Happ J; Hartmann U; Weber T; Cordes U; Beyer J
    Fertil Steril; 1978 Dec; 30(6):666-73. PubMed ID: 365598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of delayed puberty by intranasal application of gonadotropin-releasing hormone (GnRH).
    Happ J; Schmitz V; Cordes U; Krause U; Atzpodien W; Beyer J
    Int J Fertil; 1980; 25(3):247-55. PubMed ID: 6108936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cryptorchidism with a potent analog of gonadotropin-releasing hormone.
    Happ J; Weber T; Callensee W; Ermert JA; Eshkol A; Beyer J
    Fertil Steril; 1978 May; 29(5):552-6. PubMed ID: 27392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of (6-D-(O-TERT-B)-Ser)-gonadoliberin-(1--9) nonapeptide-ethylamide on gonadotropin release in prepubertal boys.
    Schönberger W; Grimm W; Ziegler R
    Horm Metab Res; 1979 Jun; 11(6):389-91. PubMed ID: 381139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine analysis of childhood monorchism.
    Palmer LS; Gill B; Kogan SJ
    J Urol; 1997 Aug; 158(2):594-6. PubMed ID: 9224372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The status of the gonadotropin releasing hormone test in differential diagnosis of delayed puberty in adolescents over 14 years of age].
    Jungmann E; Trautermann C
    Med Klin (Munich); 1994 Oct; 89(10):529-33. PubMed ID: 7808353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.
    Wilson DA; Hofman PL; Miles HL; Unwin KE; McGrail CE; Cutfield WS
    J Pediatr; 2006 Jan; 148(1):89-94. PubMed ID: 16423605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
    Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
    J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary response to luteinizing hormone-releasing hormone analog at sea level and high altitudes.
    Paredes Suarez M; Varea Teran JR; Garces G; Avila C; Coy DH; Schally AV
    Obstet Gynecol; 1982 Jan; 59(1):52-7. PubMed ID: 6804897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum gonadotropin isoforms become more basic after an exogenous challenge of gonadotropin-releasing hormone in children undergoing pubertal development.
    Phillips DJ; Wide L
    J Clin Endocrinol Metab; 1994 Sep; 79(3):814-9. PubMed ID: 8077366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gonadotropin secretion after stimulation with a highly effective analog of the gonadotropin-releasing-hormone (GnRH) in normal adult human males (author's transl)].
    Weber T; Happ J; Krause U; Beyer J
    Klin Wochenschr; 1978 Apr; 56(7):363-4. PubMed ID: 347162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrine studies on the Prader-Labhart-Willi syndrome: puberty induction in a 19-year-old boy after long-term treatment with an LHRH analog].
    Weninger M; Frisch H; Widhalm K; Schernthaner G
    Exp Clin Endocrinol; 1983 Jul; 82(1):8-14. PubMed ID: 6413233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism.
    Grinspon RP; Ropelato MG; Gottlieb S; Keselman A; Martínez A; Ballerini MG; Domené HM; Rey RA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2811-8. PubMed ID: 20371659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma gonadotropin and gonadotropin-releasing hormone levels after intranasal administration of gonadotropin releasing hormone.
    Katz M; Pimstone BL; Carr PJ; Hendricks S
    J Clin Endocrinol Metab; 1976 Jul; 43(1):215-21. PubMed ID: 780366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of cryptorchism using D-leu6-des-gly10-GnRH-ethylamide, a highly effective analog of gonadotropin-releasing hormone (GnRH=LH-RH)].
    Weber T; Happ J; Callensee W; Ermert JA; Beyer J
    Cesk Pediatr; 1978 Oct; 33(10):613-4. PubMed ID: 31982
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonadotropin responses and metabolism of synthetic gonadotropin-releasing hormone (GnRH) during constant infusion of GnRH in men and boys with delayed adolescence.
    Huseman CA; Kelch RP
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1325-31. PubMed ID: 122428
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy.
    Happ J; Kollmann F; Krawehl C; Neubauer M; Krause U; Demisch K; Sandow J; Von Rechenberg W; Beyer J
    Fertil Steril; 1978 May; 29(5):546-51. PubMed ID: 27391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing activity of two highly active and long-acting analogs of luteinizing hormone-releasing hormone after subcutaneous, intravaginal, and oral administration.
    de la Cruz A; de la Cruz KG; Arimura A; Coy DH; Vilchez-Martinez JA; Coy EJ; Schally AV
    Fertil Steril; 1975 Sep; 26(9):894-900. PubMed ID: 1102342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.